Background

Paul Mingay is a partner at our Toronto office and is the national co-ordinator of the Securities and Capital Markets Group. He graduated from the Faculty of Law at the University of Toronto in 1979 and was called to the Ontario Bar in 1981. Prior to law school, he attended Queen's University at Kingston, Ontario where he majored in economics.

Areas of Practice

• Paul's practice focuses on corporate and securities law, including mergers and acquisitions and corporate finance.
• Paul has particular industry experience in health care (including pharma and biotech), mining and infrastructure and in acting for private equity investors.

Rankings and Recognitions

• Selected by peers for inclusion in the 2010 edition of The Best Lawyers in Canada (Securities Law)
• Martindale-Hubbell AV® Preeminent™ 5.0 out of 5 Peer Review Rating
• Recognized in the 2009 Lexpert/American Lawyer Guide to the Leading 500 Lawyers in Canada
• Recognized in the 2009 Canadian Legal Lexpert Directory

Professional Experience

• Advising clients in connection with securities law matters as well as general corporate and commercial law, including contracts, and corporate governance.
• Advises both underwriters and issuers in various types of financings by public offering and private placement, including MJDS and other cross-border financings, for example: common shares (Cameco, Loblaws, Centerra Gold, MOSAID Technologies, Emco, Falconbridge, Rio Narcea Gold Mines, Drug Royalty); medium term notes (Weston, Loblaw); income trusts (Chartwell Seniors Housing REIT); preferred shares (Weston, Loblaws, Fortis); preferred securities (Cameco); commercial paper (Whirlpool/Inglis); debentures (Weston, Cameco); convertible debentures (Chartwell, Emco, Microbix Biosystems); and stapled units (TimberWest).
• Advises buyers and sellers in relation to mergers and acquisitions, for example: Golden Gate Capital in connection with its acquisitions of Geac and Sierra Systems Group; Global Copper in its acquisition by Teck Cominco; Modular Space Corporation in its acquisition of the modular space business of GE; Nautic Partners LLC in its acquisition of the assets of Canada Cartage Diversified Income Fund; Infor Global Solutions in its acquisition of Workbrain; Genzyme in its acquisition of the diagnostics business of Diagnostic Chemicals Limited; Loblaw in connection with its take-over of Provigo; Chartwell Seniors Housing REIT in connection with the multiple acquisitions leading to its formation and IPO and numerous acquisitions thereafter; boards of directors and special committees in connection with M & A and corporate governance matters; parties to various private acquisitions of shares and assets and in relation to mergers.
• Advised parties to restructurings, for example: as the corporate group leader in a multi disciplinary team advising Armbro (now Aecon) in its successful debt and equity restructuring under the Companies' Creditors Arrangement Act and subsequent recapitalization; advised S.G. Warburg Soditic on behalf of Swiss bondholders in the First City restructurings.

Professional and Community Activities

• Advisory Board Member of the 2009 National Post & ZSA Legal Recruitment Canadian General Counsel Legal Awards
• Former member of the Securities Advisory Committee to the Ontario Securities Commission.
• Former Director, Secretary and member of the governing Council of the Toronto Biotechnology Initiative and Co-chair of the Finance Sub-committee.
• Speaker at conferences, seminars and other programmes, including 'Advanced Mergers & Acquisitions' (Insight, May 2009) regarding hostile take-overs; 'Mergers & Acquisitions for the Mining Industry' (Canadian Institute, December 2008) regarding international transactions; "M & A Bootcamp" (Osgoode, March 2007 and 2008) regarding structuring of transactions; "Audit and Risk Committees" (Infonex, June 2002) on the subject of board committees; the "Biotech Summit" (Infonex, April 2001) on the subject of mergers and acquisitions; the "OSC Rules Course" (November 1998) on the subject of take-over bids; "Mergers & Acquisitions Deal-Making Conference" (Federated Press, April 1997) on the subject of poison pills; and BIO'94" (May, 1994) and "BioBusiness Forum" (Insight, October, 1994) on the subject of international securities offerings.
• Member of the editorial group for the firm's capital markets publication The Material Change Report and the securities law service Securities Law and Practice (Thomson Carswell).